Vote for kareem abdur-rashid

As Co-Founder and Director of Kare Chemical Technologies Inc., a pharmaceutical technology company, Kareem is dedicated to developing and commercializing innovative, sustainable solutions for a range of industrial and therapeutic applications. Kare’s current focus is in developing novel, non-psychoactive pain medicines aimed at addressing the opioid crisis.

Kare has also developed a groundbreaking method that leverages catalysis and citrus by-products (limonene) to synthesize Epidiolex, a leading children’s medicine for epilepsy. This scalable approach offers a compelling alternative to traditional plant-based sourcing, overcoming the limitations and inefficiencies of conventional extraction methods.

Vote for Robert arntfield

As Founder and CEO of Deep Breathe, Rob leads a team using AI to push the boundaries of lung ultrasound. With a background as a Professor of Medicine and experienced Critical Care physician, he’s focused on turning ultrasound expertise into practical tools that improve care at the bedside.

Rob’s work in point-of-care ultrasound is recognized internationally, including co-authoring the textbook Point-of-Care Ultrasound. At Deep Breathe, the team’s goal is simple: to make acute care diagnostics smarter, faster, and more accessible.

Vote for Jessica chalk

Jessica is tackling one of the most urgent and under-addressed issues in reproductive health: lack of access to timely, coordinated, patient-centered support. With myStoria, she’s building the infrastructure patients need to navigate complex fertility and hormonal care—and the tools clinics, insurers, and employers need to support them. Her vision is bold: a healthcare system where patients aren’t left to figure it out alone. 

Already gaining traction across Ontario, myStoria is bridging the gap between medical care and lived experience—delivering real-world insights that improve outcomes, reduce delays, and expand access for those too often left behind.

Vote for sydney robinson

Sydney is the CEO and co-founder of Vessl! Vessl is empowering folks with leg amputations and limb loss through novel prosthetic solutions.

Together with her co-founder, she has identified a medical market need, developed a patented solution, raised startup capital, and launched a business, in a span of 3 years.

Globally, a leg is amputated every 30 seconds. Unfortunately, amputees can experience poor socket fit; a misfit between their residual leg and prosthetic socket causing chafing. Thus, 16% of amputees abandon their prostheses and are unable to walk. 

Recognizing this market need, Vessl have developed the Kinn Automatic Volume Management System, the first automatic volume management socket that tightens in real time through a shock absorber mechanism and movable panels, improving mobility and comfort for amputees. Automatic adjustments are the key feature that make the Vessl device accessible to individuals with poor dexterity and sensation loss because they don’t need to consciously initiate socket adjustments.